NETS: Neuroregeneration Enhanced by Transcranial Direct Current Stimulation (TDCS) in Stroke

Sponsor
Universitätsklinikum Hamburg-Eppendorf (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00909714
Collaborator
(none)
119
11
2
147
10.8
0.1

Study Details

Study Description

Brief Summary

Testing the hypothesis that non-invasive brain stimulation by transcranial direct current stimulation (tDCS) combined with functional training in the subacute phase of first-ever stroke will enhance functional regeneration compared with a Placebo intervention.

Condition or Disease Intervention/Treatment Phase
  • Device: DC-Stimulator to apply tDCS
  • Device: DC-Stimulator to apply Sham tDCS
N/A

Detailed Description

Stroke is the leading cause of long-term disability, which significantly impairs the economic and social life of patients and society. Every year 200 000 to 250 000 patients suffer a stroke in Germany. Only a small number of the stroke survivors recover to a degree that allows them to return into their professional and private life. Despite significant efforts to develop novel and efficient treatment strategies the level of functional regeneration is still not satisfying. Thus, the development of innovative and effective treatment strategies will have a major impact for the patients' life, the society and the public health system.

Within the proposed project an innovative, non-invasive and cost effective interventional strategy, based on the combination of a specific rehabilitative training and brain stimulation by transcranial direct current stimulation (tDCS), will be used to enhance functional regeneration in stroke patients. The intervention will be applied in an early stage in which plasticity, cortical reorganization and functional improvement is most pronounced. We hypothesize that the combination of anodal tDCS delivered to the motor cortex of the affected hemisphere combined with training over a period of two weeks in the subacute stage after stroke will significantly enhance cortical plasticity, functional regeneration and long-term outcome determined by clinical and functional outcome measures compared with Placebo stimulation.

Study Design

Study Type:
Interventional
Actual Enrollment :
119 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Neuroregeneration Enhanced by TDCS in Stroke
Actual Study Start Date :
Jul 1, 2009
Anticipated Primary Completion Date :
Jun 30, 2021
Anticipated Study Completion Date :
Sep 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Anodal tDCS

Direct Current (DC)-Stimulator to apply tDCS + Training

Device: DC-Stimulator to apply tDCS
Anodal tDCS (20 minutes) stimulation will be applied once a day in combination with standardized upper extremity rehabilitative training

Sham Comparator: Sham tDCS

Direct Current (DC)-Stimulator to apply Sham tDCS (Placebo) + Training

Device: DC-Stimulator to apply Sham tDCS
Sham stimulation will be applied once a day in combination with standardized upper extremity rehabilitative training

Outcome Measures

Primary Outcome Measures

  1. Upper Extremity Fugl-Meyer-Assessment (UEFMA) [1-7 days after the end of the intervention]

    standardized test of upper extremity function

Secondary Outcome Measures

  1. Upper Extremity Fugl-Meyer-Assessment (UEFMA) [30±10 days after the intervention]

    standardized test of upper extremity function

  2. Upper Extremity Fugl-Meyer-Assessment (UEFMA) [90±20 days after the intervention]

    standardized test of upper extremity function

  3. Upper Extremity Fugl-Meyer-Assessment (UEFMA) | Long-term outcome [12±1 months after the intervention]

    standardized test of upper extremity function

  4. Action Research Arm Test (ARAT) [1-7 days after the end of the intervention]

    standardized tests of upper extremity function

  5. Action Research Arm Test (ARAT) [30±10 days after the intervention]

    standardized tests of upper extremity function

  6. Action Research Arm Test (ARAT) [90±20 days after the intervention]

    standardized tests of upper extremity function

  7. Action Research Arm Test (ARAT) | Long-term outcome [12±1 months after the intervention]

    standardized tests of upper extremity function

  8. Nine Hole Peg Test (NHPT) [1-7 days after the end of the intervention]

    standardized test to assess fine motor skills

  9. Nine Hole Peg Test (NHPT) [30±10 days after the intervention]

    standardized test to assess fine motor skills

  10. Nine Hole Peg Test (NHPT) [90±20 days after the intervention]

    standardized test to assess fine motor skills

  11. Nine Hole Peg Test (NHPT) | Long-term outcome [12±1 months after the intervention]

    standardized test to assess fine motor skills

  12. Stroke Impact Scale (SIS) [1-7 days after the end of the intervention]

    questionnaire is to evaluate how stroke has impacted health and life of patients

  13. Stroke Impact Scale (SIS) [30±10 days after the intervention]

    questionnaire is to evaluate how stroke has impacted health and life of patients

  14. Stroke Impact Scale (SIS) [90±20 days after the intervention]

    questionnaire is to evaluate how stroke has impacted health and life of patients

  15. Stroke Impact Scale (SIS) | Long-term outcome [12±1 months after the intervention]

    questionnaire is to evaluate how stroke has impacted health and life of patients

  16. Box-and-Block Test [1-7 days after the end of the intervention]

    standardized test to assess fine motor skills

  17. Box-and-Block Test [30±10 days after the intervention]

    standardized test to assess fine motor skills

  18. Box-and-Block Test [90±20 days after the intervention]

    standardized test to assess fine motor skills

  19. Box-and-Block Test [12±1 months after the intervention]

    standardized test to assess fine motor skills

  20. Grip Force [1-7 days after the end of the intervention]

    dynamometer-based test to assess grip strength

  21. Grip Force [30±10 days after the intervention]

    dynamometer-based test to assess grip strength

  22. Grip Force [90±20 days after the intervention]

    dynamometer-based test to assess grip strength

  23. Grip Force [12±1 months after the intervention]

    dynamometer-based test to assess grip strength

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subacute stroke patients (5-45 days after stroke) with thromboembolic non-hemorrhagic subcortical or cortical, first clinically overt stroke will be included. Moderate to moderately severe upper-extremity hemiparesis, defined as an Upper Extremity Fugl-Meyer score (UEFMA) between 20 and 58 (inclusive).
Exclusion Criteria:
  • pre-existing large lesions (> 1.5 cm maximum diameter) in a brain area that belongs to the anatomically established sensorimotor/premotor system

  • progressive stroke

  • completely lesioned hand knob area of M1 affected if no motor evoked potentials (MEPs) elicited by transcranial magnetic stimulation (TMS) are present

  • bilateral motor impairment

  • florid alcohol and/or drug abuse

  • florid severe psychiatric illness (e.g. schizophrenia)

  • severe language disturbances that prevents the patient to give informed consent or inhibit adequate scoring because of insufficient understanding of scoring introductions

  • tumor diseases with a life expectancy less than one year

  • increased intracranial pressure

  • polyneuropathy and/or ischemic peripheral disease if the sensorimotor functions of the upper extremities are affected clinically relevant

  • severe cognitive deficits (MMSE ≤ 23)

  • pregnancy

  • contraindication for MRI or TMS

Contacts and Locations

Locations

Site City State Country Postal Code
1 Neurologische Universitätsklinik Wien Wien Austria 1090
2 Klinik Kipfenberg Kipfenberg Bayern Germany 85110
3 Brandenburgklinik Berlin-Brandenburg Bernau bei Berlin Berlin Germany 16321
4 Neurologie Moritzklinik Bad Klosterlausnitz Thüringen Germany 07639
5 Neurologische Klinik Bad Aibling Bad Aibling Germany 83043
6 Neurologisches Zentrum Segeberger Kliniken Bad Segeberg Germany 23795
7 NRZ Leipzig Bennewitz Germany 04828
8 MEDIAN Klinik Berlin-Kladow Berlin Germany 14089
9 University Medical Center Hamburg Eppendorf (UKE) Hamburg Germany 20246
10 University Medical Center Heidelberg Heidelberg Germany 69120
11 Fondazione Santa Lucia Rome Italy 00179

Sponsors and Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

Investigators

  • Principal Investigator: Christian Gerloff, Prof. Dr., Department of Neurology, University Medical Center Hamburg-Eppendorf

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Universitätsklinikum Hamburg-Eppendorf
ClinicalTrials.gov Identifier:
NCT00909714
Other Study ID Numbers:
  • NETS Trial
First Posted:
May 28, 2009
Last Update Posted:
May 4, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by Universitätsklinikum Hamburg-Eppendorf
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 4, 2021